News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer
Sep 19, 2024, 12:03

Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer

Dana-Farber’s Breast Oncology Center shared on X:

“Hot off the Press!

Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer with or without Brain Metastases practice changing results from a phase 3b/4 trial.”

Breast Cancer

Source: Dana-Farber’s Breast Oncology Center/X

brain metastasis Breast Cancer breast oncology cancer Dana-Farber’s Breast Oncology Center OncoDaily Oncology Trastuzumab deruxtecan
Special Coverage
Insight
Jan 7, 2025, 19:36
Ravi Parikh: TrialTranslator – a machine learning framework for individualized cancer trial emulation
Opinion
Jan 7, 2025, 19:33
Senthil Kumar: Metastatic Urothelial Carcinoma - First line therapies
Insight
Jan 7, 2025, 18:38
Concomitant PPIs and capecitabine-based chemoradiotherapy in rectal cancer
Career
Jan 7, 2025, 18:04
Pamela Kunz: I’ve been promoted to Professor of Medicine (Oncology)
Insight
Jan 7, 2025, 18:04
The KCA's Patient Assistance Fund is open
Insight
Jan 7, 2025, 18:04
Stephen Liu: What is the best way to assess response of brain metastases to systemic treatment?
Insight
Jan 7, 2025, 18:04
Ilaria Colombo: Important publication on a high unmet need in ovarian cancer
Blog
Jan 7, 2025, 18:03
Cancer isn’t just battled in hospitals - Cancer Fight Tanzania
Insight
Jan 7, 2025, 17:59
Sahar Mansour: AI Detects Hidden Breast Carcinomas, an Egyptian Experience
Insight
Jan 7, 2025, 17:59
Transforming Cancer Care with ADCAN
Blog
Jan 7, 2025, 17:58
The fight against childhood cancer is a collective effort - The Dorcas Cancer Foundation
Blog
Jan 7, 2025, 17:57
Preventing cervical cancer with HPV vaccination and regular screenings - NCI Division of Cancer Prevention